Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9234269rdf:typepubmed:Citationlld:pubmed
pubmed-article:9234269lifeskim:mentionsumls-concept:C0004927lld:lifeskim
pubmed-article:9234269lifeskim:mentionsumls-concept:C1622418lld:lifeskim
pubmed-article:9234269lifeskim:mentionsumls-concept:C0023779lld:lifeskim
pubmed-article:9234269lifeskim:mentionsumls-concept:C0456603lld:lifeskim
pubmed-article:9234269lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:9234269lifeskim:mentionsumls-concept:C0013682lld:lifeskim
pubmed-article:9234269lifeskim:mentionsumls-concept:C0205148lld:lifeskim
pubmed-article:9234269lifeskim:mentionsumls-concept:C0032521lld:lifeskim
pubmed-article:9234269lifeskim:mentionsumls-concept:C0332256lld:lifeskim
pubmed-article:9234269lifeskim:mentionsumls-concept:C1548779lld:lifeskim
pubmed-article:9234269lifeskim:mentionsumls-concept:C1947902lld:lifeskim
pubmed-article:9234269lifeskim:mentionsumls-concept:C2827499lld:lifeskim
pubmed-article:9234269lifeskim:mentionsumls-concept:C1550605lld:lifeskim
pubmed-article:9234269lifeskim:mentionsumls-concept:C0456205lld:lifeskim
pubmed-article:9234269lifeskim:mentionsumls-concept:C1167624lld:lifeskim
pubmed-article:9234269lifeskim:mentionsumls-concept:C1664784lld:lifeskim
pubmed-article:9234269pubmed:issue1lld:pubmed
pubmed-article:9234269pubmed:dateCreated1997-9-25lld:pubmed
pubmed-article:9234269pubmed:abstractTextWhen injected intravenously, lipid vesicles labeled with 99mTc by means of a lipophilic chelator dipalmitoylphosphatidylethanolamine-diethylenetriaminetetraacetic acid (PE-DTTA) are rapidly accumulated by the mononuclear phagocytic system (MPS). By derivatizing the membrane surface with the lipid-polymer complex dipalmitoylphosphatidylethanolamine-monomethoxy polyethylene glycol 5000 (PE-MPEG), MPS uptake can be suppressed and loss of 99mTc label from the lipid surface reduced depending upon both PE-DTTA and PE-MPEG content. For vesicles containing 20% PE-DTTA, addition of PE-MPEG makes no difference to their rate of clearance from the circulation. However for vesicles containing 2% PE-DTTA, addition of more than 0.8% PE-MPEG increases circulation half-life, suppresses liver uptake and reduces renal clearance of the 99mTc label. The molar ratio of reducing agent (Sn) to chelator (PE-DTTA) is critical to efficient and reproducible labeling. For vesicles containing 2% PE-DTTA at a lipid concentration of 100 mM, a Sn/DTTA ratio of 0.35 gives close to optimal labeling. Variation in the Sn/DTTA ratio by a factor of two negatively impacts upon both labeling efficiency in vitro and circulation half-life in vivo. Potential uses for technetium-labeled lipid vesicles with extended circulation half-life are discussed.lld:pubmed
pubmed-article:9234269pubmed:languageenglld:pubmed
pubmed-article:9234269pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9234269pubmed:citationSubsetIMlld:pubmed
pubmed-article:9234269pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9234269pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9234269pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9234269pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9234269pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9234269pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9234269pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9234269pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9234269pubmed:statusMEDLINElld:pubmed
pubmed-article:9234269pubmed:monthJanlld:pubmed
pubmed-article:9234269pubmed:issn0969-8051lld:pubmed
pubmed-article:9234269pubmed:authorpubmed-author:FisherDDlld:pubmed
pubmed-article:9234269pubmed:authorpubmed-author:AhkongQ FQFlld:pubmed
pubmed-article:9234269pubmed:authorpubmed-author:TilcockCClld:pubmed
pubmed-article:9234269pubmed:issnTypePrintlld:pubmed
pubmed-article:9234269pubmed:volume21lld:pubmed
pubmed-article:9234269pubmed:ownerNLMlld:pubmed
pubmed-article:9234269pubmed:authorsCompleteYlld:pubmed
pubmed-article:9234269pubmed:pagination89-96lld:pubmed
pubmed-article:9234269pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9234269pubmed:meshHeadingpubmed-meshheading:9234269-...lld:pubmed
pubmed-article:9234269pubmed:meshHeadingpubmed-meshheading:9234269-...lld:pubmed
pubmed-article:9234269pubmed:meshHeadingpubmed-meshheading:9234269-...lld:pubmed
pubmed-article:9234269pubmed:meshHeadingpubmed-meshheading:9234269-...lld:pubmed
pubmed-article:9234269pubmed:meshHeadingpubmed-meshheading:9234269-...lld:pubmed
pubmed-article:9234269pubmed:meshHeadingpubmed-meshheading:9234269-...lld:pubmed
pubmed-article:9234269pubmed:meshHeadingpubmed-meshheading:9234269-...lld:pubmed
pubmed-article:9234269pubmed:meshHeadingpubmed-meshheading:9234269-...lld:pubmed
pubmed-article:9234269pubmed:meshHeadingpubmed-meshheading:9234269-...lld:pubmed
pubmed-article:9234269pubmed:meshHeadingpubmed-meshheading:9234269-...lld:pubmed
pubmed-article:9234269pubmed:meshHeadingpubmed-meshheading:9234269-...lld:pubmed
pubmed-article:9234269pubmed:year1994lld:pubmed
pubmed-article:9234269pubmed:articleTitle99mTc-labeling of lipid vesicles containing the lipophilic chelator PE-DTTA: effect of tin-to-chelate ratio, chelate content and surface polymer on labeling efficiency and biodistribution behavior.lld:pubmed
pubmed-article:9234269pubmed:affiliationDepartment of Radiology, University of British Columbia, Vancouver, Canada.lld:pubmed
pubmed-article:9234269pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9234269pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9234269lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9234269lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9234269lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9234269lld:pubmed